Clinical trials of UFH - TrialResults-center.org

Trial	Studied trt	Control trt	patients	ROB	Trial result	Deep vein thrombosis
Group by... in first in second in third	Synopsis Comparison Treatments Patients Characteristics Method Risk of bias References None Tools Indexation				Global trial result Main results All results All result tag NCT results	Numeric bar chart forest plot medians
acute coronary syndrome
Holdright, 1994	UFH	control (on top of aspirin)			negative
RISC (heparin+aspirin vs ASP), 1990	UFH	control (on top of aspirin)			negative
Theroux (heparin+ASP vs ASP), 1988	UFH	control (on top of aspirin)		Low risk of bias	suggesting
ATACS (Cohen), 1994	UFH, warfarin	control (on top of aspirin)			negative
Cohen (ATACS pilot) (heparin+aspirin vs asp), 1990	UFH, warfarin	control (on top of aspirin)			negative
Theroux (heparin vs PBO), 1988	UFH	placebo		Low risk of bias	suggesting
RISC (heparin vs PBO), 1990	UFH	placebo			negative
Theroux (heparin+aspirin vs PBO), 1988	UFH + aspirin	placebo		Low risk of bias	suggesting
RISC (ASP+ heparin vs PBO), 1990	UFH + aspirin	placebo			suggesting
Gurfinkel (UFH+aspririn vs aspirin), 1995	UFH	placebo (on top of aspirin)		Low risk of bias	negative
Cohen (ATACS pilot) (heparin vs asp), 1990	UFH, warfarin	aspirin			negative
acute myocardial infarction
ISIS-2 Pilot, 1987	UFH	no heparin			negative
DUCCS, 1994	UFH	no heparin			negative
ECSG, 1992	UFH	placebo		Low risk of bias	negative
OSIRIS, 1992	UFH	placebo		Low risk of bias	negative
peripheral vascular diseases
Antonicelli, 1999	HNF	placebo			-
Tesi, 1989	HNF	placebo			-
superficial thrombophlebitis
Belcaro (prophylactic UFH vs no), 1999	Prophylactic UFH	no treatment			-
thrombosis prevention
Killewich, 1997	IPC + UFH	control			negative
Blech, 1981	UFH	control	medical patients		suggesting
Cade	UFH	control	medical patients		-
Gardlund, 1996	UFH	control	medical patients		suggesting
Handley (low dose), 1972	UFH	control		Risk of bias	negative
Handley, 1972	UFH	control		Risk of bias	negative
Gallus, 1973	UFH	control		Risk of bias	negative
Emerson, 1973	UFH	control		Risk of bias	suggesting
Zawilska, 1989	UFH	control		Risk of bias	suggesting
Warlow, 1973	UFH	control		Low risk of bias	suggesting
Morris, 1974	UFH	no treatment			suggesting
Welin-Berger, 1982	UFH	no treatment			negative
Bergqvist , 1979	UFH	no treatment			suggesting
Gallus , 1973	UFH	no treatment			negative
VTCSG, 1975	UFH	no treatment			negative
Mannucci , 1976	UFH	no treatment			suggesting
Dechavanne, 1974	UFH	no treatment			suggesting
Dechavanne, 1975	UFH	no treatment			suggesting
Bergqvist, 1979	UFH	no treatment			suggesting
Galasko , 1976	UFH	no treatment			suggesting
Gallus , 1973	UFH	no treatment			suggesting
Morris , 1977	UFH	no treatment			negative
Kakkar (IMT)	UFH	no treatment			-
Gruber	UFH	no treatment			-
Gordon-Smith, 1972	UFH	no treatment			-
Nicolaides, 1972	UFH	no treatment			-
Multiunit, 1974	UFH	no treatment			-
Abernethy, 1974	UFH	no treatment			-
Clarke-Pearson, 1983	UFH	no treatment			-
Plante, 1979	UFH	no treatment			-
Abraham-Inpijn, 1979	UFH	no treatment			-
Spebar, 1981	UFH	no treatment			-
Sagar, 1974	UFH	no treatment			-
Koppenhagen, 1982	UFH	no treatment			-
Bergqvist, 1980	UFH	no treatment			-
Gallus, 1973	UFH	no treatment			-
Gallus, 1976	UFH	no treatment			-
Groote Schuur, 1979	UFH	no treatment			-
Kraytman, 1976	UFH	no treatment			-
Kraytman, 1977	UFH	no treatment			-
Kettunen, 1974	UFH	no treatment			-
Caloghera, 1984	UFH	no treatment			-
Marchelli, 1983	UFH	no treatment			-
Ziemski, 1979	UFH	no treatment			-
Coe, 1978	UFH	no treatment			-
Sebeseri, 1975	UFH	no treatment			-
Allen, 1978	UFH	no treatment			-
Cerrato, 1978	UFH	no treatment			suggesting
Williams , 1978	UFH	placebo			negative
Abraham-Inpijn , 1975	UFH	placebo			negative
Lowe , 1981	UFH	placebo			suggesting
Hampson, 1974	UFH	placebo			negative
Moskovitz, 1978	UFH	placebo			suggesting
Lahnborg, 1980	UFH	placebo			suggesting
Xabregas , 1977	UFH	placebo			negative
Moskovitz, 1978	UFH	placebo			negative
Svend-Hansen, 1981	UFH	placebo			suggesting
Kakkar, 1972	UFH	placebo			-
Kiil, 1978	UFH	placebo			-
Torngren, 1978	UFH	placebo			-
Torngren	UFH	placebo			-
Lahnborg, 1975	UFH	placebo			-
Lahnborg, 1976	UFH	placebo			-
Covey, 1975	UFH	placebo			-
Belch, 1980	UFH	placebo			-
Taberner, 1978	UFH	placebo			-
Strand, 1975	UFH	placebo			-
Roberts, 1975	UFH	placebo			-
Ribaudo, 1975	UFH	placebo			-
Wu, 1977	UFH	placebo			-
Lawrence, 1977	UFH	placebo			-
Muiticentre, 1984	UFH	placebo			-
Jourdan, 1984	UFH	placebo			-
Torngren, 1978	UFH	placebo			-
Kruse-Blinkenberg, 1980	UFH	placebo			-
Kraytman, 1977	UFH	placebo			-
Marchetti, 1982	UFH	placebo			-
Bejjani, 1983	UFH	placebo			-
Hedlund, 1979	UFH	placebo			-
Kutnowski, 1977	UFH	placebo			-
Vandendris, 1980	UFH	placebo			-
Pitt, 1980	UFH	placebo		Risk of bias	negative
Siragusa (H), 1994	IPC + UFH	UFH			negative
Ramos, 1996	IPC + UFH	UFH			suggesting
Loew, 1977	UFH	aspirin			-
Vinazzer, 1980	UFH	aspirin			-
Muiticentre 53,S4, 1984	UFH	DHE			-
Muiticentre, 1984	UFH	DHE			-
van Geloven, 1977	UFH	oral anticoagulant			-
Manganelli, 1998	out of hospital UFH	standard prophylaxis			negative
Wille-Jorgensen, 1991	GCS + UFH	UFH			suggesting
Wille-Jorgensen, 1985	GCS + UFH	UFH			suggesting
*Rasmussen (adj), 1988	GCS + UFH	UFH			negative
Torngren, 1980	GCS + UFH	UFH			suggesting

UFH antithrombotics systematic review meta-analysis network meta-analysis

Group by...

acute coronary syndrome

acute myocardial infarction

peripheral vascular diseases

superficial thrombophlebitis

thrombosis prevention

UFH antithrombotics
systematic review meta-analysis network meta-analysis